3,4-methylenedioxyamphetamine has been researched along with Mitral Valve Insufficiency in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Mitral Valve Insufficiency: Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tribouilloy, C | 1 |
| Bohbot, Y | 1 |
| Unger, P | 1 |
1 other study available for 3,4-methylenedioxyamphetamine and Mitral Valve Insufficiency
| Article | Year |
|---|---|
Mitral Regurgitation in Patients With Severe Aortic Regurgitation: When Misery Loves Company.
Topics: Aortic Valve; Aortic Valve Insufficiency; Heart Valve Prosthesis Implantation; Humans; Love; Mitral | 2020 |